Canine CXCL7 and its functional expression in dendritic cells undergoing maturation

Veterinary Immunology and Immunopathology

Volumn 135, Issue 1-2, 2010, Pages 128-136

  Wang, Yu Shan ^a,b   Liao, Kuang Wen ^c   Chen, Mo Fen ^a   Huang, Yi Chun ^a   Chu, Rea Min ^a   Chi, Kwan Hwa ^b,d  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b SHIN KONG WU HO SU MEMORIAL HOSPITAL   (Taiwan)

^c Immunology and Biopharmaceutics   (Taiwan)

^d NONE   (Taiwan)

Author keywords

Canine; Chemokine; CXCL7; Dendritic cells

Indexed keywords

CHEMOKINE; COMPLEMENTARY DNA; CXCL7 CHEMOKINE; GAMMA INTERFERON; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; LYMPHOTOXIN; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BIOLOGICAL ACTIVITY; CELL FUNCTION; CELL MATURATION; CELL STIMULATION; CELL STRAIN 3T3; CONTROLLED STUDY; DENDRITIC CELL; DNA SEQUENCE; DOG; FEMALE; GENE EXPRESSION REGULATION; IMMUNOMODULATION; INFLAMMATION; MALE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN ISOLATION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING;

ANIMALS; BALB 3T3 CELLS; BLOTTING, WESTERN; CHEMOKINES, CXC; CHEMOTAXIS, LEUKOCYTE; CLONING, MOLECULAR; DENDRITIC CELLS; DNA, COMPLEMENTARY; DOGS; FEMALE; GENE EXPRESSION; LEUKOCYTES, MONONUCLEAR; MALE; MICE; NEUTROPHILS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEQUENCE ALIGNMENT; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

CANIS FAMILIARIS;

EID: 77951205498     PISSN: 01652427     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetimm.2009.11.011     Document Type: Article

References (51)

1. Arenberg D.A., Keane M.P., DiGiovine B., Kunkel S.L., Morris S.B., Xue Y.Y., Burdick M.D., Glass M.C., Iannettoni M.D., Strieter R.M. Epithelial-neutrophil activating peptide (ENA-78) is an important angiogenic factor in non-small cell lung cancer. J. Clin. Invest. 1998, 102:465-472.
2. Arenberg D.A., Kunkel S.L., Polverini P.J., Glass M., Burdick M.D., Strieter R.M. Inhibition of interleukin-8 reduces tumorigenesis of human non-small cell lung cancer in SCID mice. J. Clin. Invest. 1996, 97:2792-2802.
3. Baggiolini M. Activation and recruitment of neutrophil leukocytes. Clin. Exp. Immunol. 1995, 101(Suppl. 1):5-6.
4. Baldwin E.T., Weber I.T., St Charles R., Xuan J.C., Appella E., Yamada M., Matsushima K., Edwards B.F., Clore G.M., Gronenborn A.M., et al. Crystal structure of interleukin 8: symbiosis of NMR and crystallography. Proc. Natl. Acad. Sci. U.S.A. 1991, 88:502-506.
5. Banchereau J., Briere F., Caux C., Davoust J., Lebecque S., Liu Y.J., Pulendran B., Palucka K. Immunobiology of dendritic cells. Annu. Rev. Immunol. 2000, 18:767-811.
6. Banchereau J., Steinman R.M. Dendritic cells and the control of immunity. Nature 1998, 392:245-252.
7. Border W.A., Ruoslahti E. Transforming growth factor-beta in disease: the dark side of tissue repair. J. Clin. Invest. 1992, 90:1-7.
8. Brandt E., Ludwig A., Petersen F., Flad H.D. Platelet-derived CXC chemokines: old players in new games. Immunol. Rev. 2000, 177:204-216.
9. Bromley S.K., Burack W.R., Johnson K.G., Somersalo K., Sims T.N., Sumen C., Davis M.M., Shaw A.S., Allen P.M., Dustin M.L. The immunological synapse. Annu. Rev. Immunol. 2001, 19:375-396.
10. Clark G.J., Angel N., Kato M., Lopez J.A., MacDonald K., Vuckovic S., Hart D.N. The role of dendritic cells in the innate immune system. Microbes Infect. 2000, 2:257-272.
11. Di Carlo E., Forni G., Lollini P., Colombo M.P., Modesti A., Musiani P. The intriguing role of polymorphonuclear neutrophils in antitumor reactions. Blood 2001, 97:339-345.
12. Feniger-Barish R., Ran M., Zaslaver A., Ben-Baruch A. Differential modes of regulation of cxc chemokine-induced internalization and recycling of human CXCR1 and CXCR2. Cytokine 1999, 11:996-1009.
13. Foti M., Granucci F., Aggujaro D., Liboi E., Luini W., Minardi S., Mantovani A., Sozzani S., Ricciardi-Castagnoli P. Upon dendritic cell (DC) activation chemokines and chemokine receptor expression are rapidly regulated for recruitment and maintenance of DC at the inflammatory site. Int. Immunol. 1999, 11:979-986.
14. Gewirtz A.M., Zhang J., Ratajczak J., Ratajczak M., Park K.S., Li C., Yan Z., Poncz M. Chemokine regulation of human megakaryocytopoiesis. Blood 1995, 86:2559-2567.
15. Hart D.N. Dendritic cells: unique leukocyte populations which control the primary immune response. Blood 1997, 90:3245-3287.
16. Hurst S.M., Wilkinson T.S., McLoughlin R.M., Jones S., Horiuchi S., Yamamoto N., Rose-John S., Fuller G.M., Topley N., Jones S.A. Il-6 and its soluble receptor orchestrate a temporal switch in the pattern of leukocyte recruitment seen during acute inflammation. Immunity 2001, 14:705-714.
17. Iida N., Haisa M., Igarashi A., Pencev D., Grotendorst G.R. Leukocyte-derived growth factor links the PDGF and CXC chemokine families of peptides. FASEB J. 1996, 10:1336-1345.
18. Jonuleit H., Giesecke-Tuettenberg A., Tuting T., Thurner-Schuler B., Stuge T.B., Paragnik L., Kandemir A., Lee P.P., Schuler G., Knop J., Enk A.H. A comparison of two types of dendritic cell as adjuvants for the induction of melanoma-specific T-cell responses in humans following intranodal injection. Int. J. Cancer 2001, 93:243-251.
19. Khajoee V., Saito M., Takada H., Nomura A., Kusuhara K., Yoshida S.I., Yoshikai Y., Hara T. Novel roles of osteopontin and CXC chemokine ligand 7 in the defence against mycobacterial infection. Clin. Exp. Immunol. 2006, 143:260-268.
20. Kruidenier L., MacDonald T.T., Collins J.E., Pender S.L.F., Sanderson I.R. Myofibroblast matrix metalloproteinases activate the neutrophil chemoattractant CXCL7 from intestinal epithelial cells. Gastroenterology 2006, 130:127-136.
21. Lanzavecchia A., Sallusto F. Dynamics of T lymphocyte responses: intermediates, effectors, and memory cells. Science 2000, 290:92-97.
22. Le Naour F., Hohenkirk L., Grolleau A., Misek D.E., Lescure P., Geiger J.D., Hanash S., Beretta L. Profiling changes in gene expression during differentiation and maturation of monocyte-derived dendritic cells using both oligonucleotide microarrays and proteomics. J. Biol. Chem. 2001, 276:17920-17931.
23. Liao K.W., Hung S.W., Hsiao Y.W., Bennett M., Chu R.M. Canine transmissible venereal tumor cell depletion of B lymphocytes: molecule(s) specifically toxic for B cells. Vet. Immunol. Immunopathol. 2003, 92:149-162.
24. Lichtenberger C., Zakeri S., Baier K., Willheim M., Holub M., Reinisch W. A novel high-purity isolation method for human peripheral blood neutrophils permitting polymerase chain reaction-based mRNA studies. J. Immunol. Methods 1999, 227:75-84.
25. Lucila Scimone M., Lutzky V.P., Zittermann S.I., Maffia P., Jancic C., Buzzola F., Issekutz A.C., Chuluyan E. Migration of polymorphonuclear leucocytes is influenced by dendritic cells. Immunology 2005, 114:375-385.
26. Malkowski M.G., Lazar J.B., Johnson P.H., Edwards B.F. The amino-terminal residues in the crystal structure of connective tissue activating peptide-III (des10) block the ELR chemotactic sequence. J. Mol. Biol. 1997, 266:367-380.
27. Malkowski M.G., Wu J.Y., Lazar J.B., Johnson P.H., Edwards B.F. The crystal structure of recombinant human neutrophil-activating peptide-2 (M6L) at 1.9-A resolution. J. Biol. Chem. 1995, 270:7077-7087.
28. McColl S.R. Chemokines and dendritic cells: a crucial alliance. Immunol. Cell Biol. 2002, 80:489-496.
29. McLoughlin R.M., Hurst S.M., Nowell M.A., Harris D.A., Horiuchi S., Morgan L.W., Wilkinson T.S., Yamamoto N., Topley N., Jones S.A. Differential regulation of neutrophil-activating chemokines by IL-6 and its soluble receptor isoforms. J. Immunol. 2004, 172:5676-5683.
30. McLoughlin R.M., Witowski J., Robson R.L., Wilkinson T.S., Hurst S.M., Williams A.S., Williams J.D., Rose-John S., Jones S.A., Topley N. Interplay between IFN-gamma and IL-6 signaling governs neutrophil trafficking and apoptosis during acute inflammation. J. Clin. Invest. 2003, 112:598-607.
31. Nagorsen D., Marincola F.M., Panelli M.C. Cytokine and chemokine expression profiles of maturing dendritic cells using multiprotein platform arrays. Cytokine 2004, 25:31-35.
32. Nielsen H., Brunak S., von Heijne G. Machine learning approaches for the prediction of signal peptides and other protein sorting signals. Protein Eng. 1999, 12:3-9.
33. Palucka K.A., Taquet N., Sanchez-Chapuis F., Gluckman J.C. Dendritic cells as the terminal stage of monocyte differentiation. J. Immunol. 1998, 160:4587-4595.
34. Park J.Y., Park K.H., Bang S., Kim M.H., Lee J.E., Gang J., Koh S.S., Song S.Y. CXCL5 overexpression is associated with late stage gastric cancer. J. Cancer Res. Clin. Oncol. 2007, 133:835-840.
35. Pillai M.M., Iwata M., Awaya N., Graf L., Torok-Storb B. Monocyte-derived CXCL7 peptides in the marrow microenvironment. Blood 2006, 107:3520-3526.
36. Power C.A., Proudfoot A.E., Magnenat E., Bacon K.B., Wells T.N. Molecular cloning and characterisation of a neutrophil chemotactic protein from porcine platelets. Eur. J. Biochem. 1994, 221:713-719.
37. Proudfoot A.E., Peitsch M.C., Power C.A., Allet B., Mermod J.J., Bacon K., Wells T.N. Structure and bioactivity of recombinant human CTAP-III and NAP-2. J. Protein Chem. 1997, 16:37-49.
38. Rossi D., Zlotnik A. The biology of chemokines and their receptors. Annu. Rev. Immunol. 2000, 18:217-242.
39. Sallusto F., Palermo B., Lenig D., Miettinen M., Matikainen S., Julkunen I., Forster R., Burgstahler R., Lipp M., Lanzavecchia A. Distinct patterns and kinetics of chemokine production regulate dendritic cell function. Eur. J. Immunol. 1999, 29:1617-1625.
40. Schaffner A., King C.C., Schaer D., Guiney D.G. Induction and antimicrobial activity of platelet basic protein derivatives in human monocytes. J. Leukoc. Biol. 2004, 76:1010-1018.
41. Schottenfeld D., Beebe-Dimmer J. Chronic inflammation: a common and important factor in the pathogenesis of neoplasia. CA Cancer J. Clin. 2006, 56:69-83.
42. St Charles R., Walz D.A., Edwards B.F. The three-dimensional structure of bovine platelet factor 4 at 3.0-A resolution. J. Biol. Chem. 1989, 264:2092-2099.
43. Tsujimoto H., Efron P.A., Matsumoto T., Ungaro R.F., Abouhamze A., Ono S., Mochizuki H., Moldawer L.L. Maturation of murine bone marrow-derived dendritic cells with poly(I:C) produces altered TLR-9 expression and response to CpG DNA. Immunol. Lett. 2006, 107:155-162.
44. Walz A., Baggiolini M. A novel cleavage product of beta-thromboglobulin formed in cultures of stimulated mononuclear cells activates human neutrophils. Biochem. Biophys. Res. Commun. 1989, 159:969-975.
45. Wan Y., Bramson J. Role of dendritic cell-derived cytokines in immune regulation. Curr. Pharm. Des. 2001, 7:977-992.
46. Wang Y.S., Chi K.H., Chu R.M. Cytokine profiles of canine monocyte-derived dendritic cells as a function of lipopolysaccharide- or tumor necrosis factor-alpha-induced maturation. Vet. Immunol. Immunopathol. 2007, 118:186-198.
47. Wang Y.S., Chi K.H., Liao K.W., Liu C.C., Cheng C.L., Lin Y.C., Cheng C.H., Chu R.M. Characterization of canine monocyte-derived dendritic cells with phenotypic and functional differentiation. Can. J. Vet. Res. 2007, 71:165-174.
48. Welch D.R., Schissel D.J., Howrey R.P., Aeed P.A. Tumor-elicited polymorphonuclear cells, in contrast to " normal" circulating polymorphonuclear cells, stimulate invasive and metastatic potentials of rat mammary adenocarcinoma cells. Proc. Natl. Acad. Sci. U.S.A. 1989, 86:5859-5863.
49. Yao V., Platell C., Hall J.C. Dendritic cells. ANZ J. Surg. 2002, 72:501-506.
50. Yoneyama H., Narumi S., Zhang Y., Murai M., Baggiolini M., Lanzavecchia A., Ichida T., Asakura H., Matsushima K. Pivotal role of dendritic cell-derived CXCL10 in the retention of T helper cell 1 lymphocytes in secondary lymph nodes. J. Exp. Med. 2002, 195:1257-1266.
51. Zhang C., Gadue P., Scott E., Atchison M., Poncz M. Activation of the megakaryocyte-specific gene platelet basic protein (PBP) by the Ets family factor PU.1. J. Biol. Chem. 1997, 272:26236-26246.